|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Harvard-MIT
* To whom correspondence should be addressed. E-mail: nikko{at}rodneyperkins.com.
Endobronchial Lung Volume Reduction (ELVR) may be helpful in a selected group of patients with advanced stages of emphysema. However, collateral ventilation (CV) from adjacent lobes through collateral channels often prevents target lobe atelectasis, which presumably mediates clinical responses after ELVR. With the goal of identifying patients who are more or less likely to benefit, we propose Endobronchial Collateral Ventilation Assessment (ECVA), a novel catheter-based endobronchial approach, to quantitatively determine the resistance of collateral channels (Rcoll). ECVA relies on the measurement of spontaneous air flow from the sealed and isolated target compartment during spontaneous respiration in an awake subject, thereby providing a direct, simple and minimally invasive method of assessing Rcoll in lungs. In this study, we validated ECVA in a controlled laboratory setup and tested ECVA's clinical feasibility in 11 emphysematous human subjects undergoing ELVR treatment. To evaluate ECVA in a controlled laboratory setup with known CV levels, we built a benchtop model mimicking a simple one-compartment model of the lungs during temporary compartmental occlusion and spontaneous respiration, which could be adapted to hold restrictors of different sizes representing collateral airways, and applied ECVA to estimate the resistance of various benchtop model restrictors. We then rated ECVA's performance by direct comparison between estimated and actual restrictor resistance and found a correlation coefficient near one. To test ECVA's clinical performance, post-ELVR radiologic assessments were made to determine the occurrence of atelectasis in the treated lobe and inter-lobar Rcoll was estimated in the target lobe via ECVA pre-ELVR. ECVA could be completed in all patients with no adverse events and a high Rcoll by ECVA predicted absorption atelectasis following ELVR (p=0.005). We believe that ECVA may be helpful to distinguish those patients with and without inter-lobar CV by identifying the critical value of Rcoll above which atelectasis is likely to occur.
This article has been cited by other articles:
![]() |
H. E. Fessler Collateral damage assessment for endobronchial lung volume reduction J Appl Physiol, March 1, 2009; 106(3): 755 - 756. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |